Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc transporter 5 (SLC30A5) is a membrane transporter responsible for mediating cellular zinc efflux and sequestration into organelles, primarily functioning in the early secretory pathway including the Golgi apparatus and vesicular compartments[1][2][3][4][5][6]. It forms heterodimers with zinc transporter 6 (SLC30A6), acting as a proton-coupled zinc antiporter critical for activation and folding of numerous zinc-dependent enzymes, such as alkaline phosphatases, and for the storage and secretion of insulin in pancreatic beta cells[1][3]. SLC30A5 is selectively essential for mast cell–mediated delayed-type allergic responses, influencing immune signaling by regulating the availability of zinc required for protein kinase C and NF-κB activation[4]. Alterations in its function have been associated with congenital disease, immune dysregulation, and possibly cancer, highlighting its significance for both basic biology and potential therapeutic targeting[3][4][5][6].
Metal ion transport modulation
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc transporter 5 (SLC30A5).